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Systemic activation of coagulation may occur in the context of
a variety of clinical situations. This coagulation activation may
only be detectable by measuring sensitive molecular markers
for activation of coagulation factors and pathways, but can
become clinically manifest as changes in routine coagulation
tests may occur [1]. The spectrum of clinically manifest
coagulation activation ranges from a small decrease in platelet
count and sub-clinical prolongation of global clotting times to
its most extreme form, for example fulminant disseminated
intravascular coagulation (DIC), characterized by gross labo-
ratory abnormalities and simultaneous widespread microvas-
cular thrombosis and profuse bleeding from various sites [2,3].
DIC is not a disease or a symptom but a syndrome, which is
always secondary to an underlying disorder. Although these
conditions may be very different, the pathogenesis of DIC
seems to follow similar lines. Brieﬂy, intravascular ﬁbrin
deposition is a result of tissue factor-mediated thrombin
generation that is insufﬁciently balanced by dysfunctional
physiologic anticoagulant mechanisms, such as the antithrom-
bin system and the protein C system [4]. In addition to
enhanced ﬁbrin formation, ﬁbrin removal is impaired as a
result of depression of the ﬁbrinolytic system caused by high
circulating levels of the ﬁbrinolytic inhibitor PAI-1.
The traditional list of underlying diseases known to be
associated with DIC includes infectious diseases, systemic
inﬂammatory conditions, trauma and cancer, obstetrical com-
plications and severe toxical and immunological reactions [3].
In this issue of the Journal of Thrombosis and Haemostasis,
Leitner et al. [5] propose to add a new diagnosis to that list.
They report on a series of 113 patients with massive pulmonary
embolism, serious enough to require cardiopulmonary resus-
citation. These patients had a prolonged prothrombin time,
lower platelet count and reduced antithrombin levels as
compared with subjects with pulmonary embolism that did
not need cardiopulmonary resuscitation. Nine percent of the
patients that needed resuscitation had DIC, according to the
criteria of the International Society of Thrombosis and
Hemostasis [6]. Based on these ﬁndings, the authors conclude
that massive pulmonary embolism could be an eliciting factor
for DIC. While this could indeed be the case, an alternative
explanation might also be proposed: cardiopulmonary collapse
and resuscitation as a consequence of the embolus rather than
the pulmonary embolism itself could be responsible for the
activation of coagulation. Indeed, several studies have indi-
cated that patients with (out of hospital) cardiac arrest display
signs of intravascular coagulation activation and subsequent
ﬁbrin deposition [7]. The mechanism underlying this wide-
spread coagulation activation may be a systemic inﬂammatory
response as a result of ischemia reperfusion in patients with
circulatory arrest and/or hypoxia [8]. Studies in patients during
and after cardiopulmonary arrest have shown enhanced tissue
factor expression in combination with reduced tissue factor
pathway inhibitor [9]. In addition, this activation of coagula-
tion and ﬁbrin formation is insufﬁciently balanced by endog-
enous ﬁbrin removal, as a result of high levels of PAI-1 [10,11].
Indeed, both mechanisms are crucial in the pathogenesis of
DIC. Contradictory to the hypothesis that the resuscitation per
se is responsible for the systemic coagulation activation Leitner
et al. has shown that patients that were resuscitated for reasons
other than pulmonary embolism (i.e. resuscitation as a result of
primary cardiac causes) had a markedly less intense activation
of coagulation than patients with pulmonary embolism. Hence,
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 2010 International Society on Thrombosis and Haemostasisit is likely that a pulmonary clot itself may contribute to the
coagulopathy. Following that conclusion, it may be suggested
that the presence of a large intravascular thrombus in the
pulmonary circulation may result in insufﬁciently contained
thrombin generation at the clot surface and overﬂow of active
coagulation factors into the systemic circulation. In that case,
extended intravascular coagulation may be a better term than
disseminated intravascular coagulation. Similarly, large aortic
aneurysms with clots in the false lumen or large arteriovascular
malformations have been associated with a consumption
coagulopathy mimicking DIC [12–15].
Another interesting ﬁnding of Leitner et al. is the predictive
valueof the DICscorefor mortality inpatientswithpulmonary
embolism. This is in complete agreement with the prognostic
utility of the DIC score in many other clinical situations [16,17].
Surprisingly, there was also a strong correlation between the
DICscoreandin-hospitalmortality inpatients withpulmonary
embolism who did not require resuscitation. This may be a
useful observation as this scoring system may be used to select
patients that need more intensive monitoring and treatment
compared with the standard management of pulmonary
embolism. For example, the use of thrombolytic treatment,
in most institutions reserved for patients who present with
pulmonary embolism complicated by severe cardiopulmonary
insufﬁciency, may result in a better outcome in these high-risk
patients. Obviously, the efﬁcacy of such an approach deﬁni-
tively needs prospective validation in a sound clinical trial,
which should also address the safety of more intense anti-
thrombotic strategies in patients with an overt coagulopathy.
In conclusion, based on the present ﬁndings massive
pulmonary embolism in combination with cardiopulmonary
resuscitation can be associated with DIC. The presence of DIC
seems to be related to an adverse outcome after pulmonary
embolism, also in patients that do not need resuscitation. These
ﬁndings may be helpful in developing more tailored manage-
ment strategies in patients that present with pulmonary
embolism.
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